{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:47:48Z","timestamp":1787021268334,"version":"build-2736575974"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,5,31]],"date-time":"2020-05-31T00:00:00Z","timestamp":1590883200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,5,31]],"date-time":"2020-05-31T00:00:00Z","timestamp":1590883200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1208\/s12249-020-01685-1","type":"journal-article","created":{"date-parts":[[2020,5,31]],"date-time":"2020-05-31T11:02:22Z","timestamp":1590922942000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["In Vitro-In Vivo Correlation for Solid Dispersion of a Poorly Water-Soluble Drug Efonidipine Hydrochloride"],"prefix":"10.1208","volume":"21","author":[{"given":"Xu","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianlong","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meijuan","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyu","family":"Piao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,31]]},"reference":[{"issue":"4","key":"1685_CR1","first-page":"1","volume":"183","author":"S Tanaka","year":"1990","unstructured":"Tanaka S, Sakai T, Masuda Y. Antihypertensive and diuretic effects of NZ-105, a novel dihydropyridine calcium antagonist. Eur J Pharmacol. 1990;183(4):1.","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"1685_CR2","first-page":"123","volume":"12","author":"Y Masuda","year":"2010","unstructured":"Masuda Y, Tanaka S. Efonidipine hydrochloride: a new calcium antagonist. Cardiovasc Ther. 2010;12(2):123\u201335.","journal-title":"Cardiovasc Ther"},{"issue":"38","key":"1685_CR3","doi-asserted-by":"publisher","first-page":"7430","DOI":"10.1039\/C5CE00751H","volume":"17","author":"M Otsuka","year":"2015","unstructured":"Otsuka M, Maeno Y, Fukami T, Inoue M, Tagamic T, Ozekic T. Developmental considerations for ethanolates with regard to stability and physicochemical characterization of efonidipine hydrochloride ethanolate. Crystengcomm. 2015;17(38):7430\u20136.","journal-title":"Crystengcomm."},{"key":"1685_CR4","unstructured":"Miyamoto M, Oda T, Bunrin T, Okabe T, Nishiyama T. Process for producing efonidipine hydrochloride preparation. United States patent US 6171599B1. 2001 Jan 09."},{"key":"1685_CR5","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.ejpb.2016.08.008","volume":"108","author":"M Otsuka","year":"2016","unstructured":"Otsuka M, Maeno Y, Fukami T, Inoue M, Tagami T, Ozeki T. Solid dispersions of efonidipine hydrochloride ethanolate with improved physicochemical and pharmacokinetic properties prepared with microwave treatment. Eur J Pharm Biopharm. 2016;108:25\u201331.","journal-title":"Eur J Pharm Biopharm"},{"issue":"3","key":"1685_CR6","doi-asserted-by":"publisher","first-page":"673","DOI":"10.3999\/jscpt.22.673","volume":"22","author":"N Mitsuyoshi","year":"1991","unstructured":"Mitsuyoshi N, Mitsutaka K, Toshihiko U, Ryuichi S, Atsuhiro M, Satoru N, et al. Pharmacokinetics and safety of NZ-105 in healthy volunteers: single-dose and multiple-dose studies. Jpn J Clin Pharmacol Ther. 1991;22(3):673\u201383.","journal-title":"Jpn J Clin Pharmacol Ther"},{"issue":"4","key":"1685_CR7","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.ejps.2004.11.007","volume":"24","author":"VH Sunesen","year":"2005","unstructured":"Sunesen VH, Pedersen BL, Kristensen HG, Mullertz A. In vivo in vitro correlations for a poorly soluble drug, danazol, using the flow-through dissolution method with biorelevant dissolution media. Eur J Pharm Sci. 2005;24(4):305\u201313.","journal-title":"Eur J Pharm Sci"},{"issue":"1","key":"1685_CR8","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jconrel.2008.05.013","volume":"130","author":"JI Jinno","year":"2008","unstructured":"Jinno JI, Kamada N, Miyake M, Yamada K, Mukai T, Odomi M, et al. In vitro\u2013in vivo correlation for wet-milled tablet of poorly water-soluble cilostazol. J Release. 2008;130(1):29\u201337.","journal-title":"J Release"},{"key":"1685_CR9","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.jconrel.2016.12.043","volume":"250","author":"CA Mccarthy","year":"2017","unstructured":"Mccarthy CA, Faisal W, O'Shea JP, Murphy C, Ahern RJ, Ryan KB, et al. In vitro dissolution models for the prediction of in vivo performance of an oral mesoporous silica formulation. J Control Release. 2017;250:86\u201395.","journal-title":"J Control Release"},{"issue":"1\u20132","key":"1685_CR10","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.ijpharm.2015.12.047","volume":"499","author":"A Mercuri","year":"2016","unstructured":"Mercuri A, Fares R, Bresciani M, Fotaki N. An in vitro\u2013in vivo correlation study for nifedipine immediate release capsules administered with water, alcoholic and non-alcoholic beverages: impact of in vitro dissolution media and hydrodynamics. Int J Pharm. 2016;499(1\u20132):330\u201342.","journal-title":"Int J Pharm"},{"issue":"2","key":"1685_CR11","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.jsps.2013.02.001","volume":"22","author":"JR Medina","year":"2014","unstructured":"Medina JR, Salazar DK, Hurtado M, Cortes AR, Dominguez-Ram\u0131rez AM. Comparative in vitro dissolution study of carbamazepine immediate-release products using the USP paddles method and the flow-through cell system. Saudi Pharmaceut J. 2014;22(2):141\u20137.","journal-title":"Saudi Pharmaceut J"},{"issue":"1\u20132","key":"1685_CR12","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S0378-5173(01)00741-4","volume":"225","author":"N Zerrouk","year":"2001","unstructured":"Zerrouk N, Chemtob C, Arnaud P, Toscani S, Dugue J. In vitro and in vivo evaluation of carbamazepine-PEG 6000 solid dispersions. Int J Pharm. 2001;225(1\u20132):49\u201362.","journal-title":"Int J Pharm"},{"key":"1685_CR13","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.1002\/jps.24362","volume":"104","author":"F Kesisoglou","year":"2015","unstructured":"Kesisoglou F, Hermans A, Neu C, Yee KL, Palcza J, Miller J. Development of in vitro-in vivo correlation for amorphous solid dispersion immediate-release Suvorexant tablets and application to clinically relevant dissolution specifications and in-process controls. J Pharm Sci. 2015;104:2913\u201322.","journal-title":"J Pharm Sci"},{"issue":"2","key":"1685_CR14","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/j.ejpb.2007.12.013","volume":"69","author":"BM Lue","year":"2008","unstructured":"Lue BM, Nielsen FS, Magnussen T, Schou HM, Kristensen K, Jacobsen LO, et al. Using biorelevant dissolution to obtain IVIVC of solid dosage forms containing a poorly-soluble model compound. Eur J Pharm Biopharm. 2008;69(2):650\u20137.","journal-title":"Eur J Pharm Biopharm"},{"key":"1685_CR15","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.ejps.2013.08.024","volume":"57","author":"ES Kostewicz","year":"2014","unstructured":"Kostewicz ES, Abrahamsson B, Brewster M, Brouwers J, Butler J, Carler S, et al. In vitro models for the prediction of in vivo performance of oral dosage forms. Eur J Pharm Sci. 2014;57:342\u201366.","journal-title":"Eur J Pharm Sci"},{"issue":"2","key":"1685_CR16","doi-asserted-by":"publisher","first-page":"6","DOI":"10.14227\/DT120205P6","volume":"12","author":"J Hu","year":"2005","unstructured":"Hu J, Kyad A, Ku V, Zhou P, Cauchon N. A comparison of dissolution testing on lipid soft gelatin capsules using USP apparatus 2 and apparatus 4. Dissolution Technol. 2005;12(2):6\u20139.","journal-title":"Dissolution Technol"},{"issue":"1","key":"1685_CR17","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.ijpharm.2010.01.009","volume":"388","author":"U Bhardwaj","year":"2010","unstructured":"Bhardwaj U, Burgess DJ. A novel USP apparatus 4 based release testing method for dispersed systems. Int J Pharm. 2010;388(1):287\u201394.","journal-title":"Int J Pharm"},{"key":"1685_CR18","doi-asserted-by":"crossref","unstructured":"Beyssac E, Lavigne J. Dissolution study of active pharmaceutical ingredients using the flow through apparatus Usp 4. Dissolution Technol. 2005;12(2).","DOI":"10.14227\/DT120205P23"},{"issue":"7","key":"1685_CR19","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1007\/s11095-008-9569-4","volume":"25","author":"E Jantratid","year":"2008","unstructured":"Jantratid E, Janssen N, Reppas C, Dressman JB. Dissolution media simulating conditions in the proximal human gastrointestinal tract: an update. Pharm Res. 2008;25(7):1663\u201376.","journal-title":"Pharm Res"},{"issue":"1","key":"1685_CR20","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/S0378-5173(02)00521-5","volume":"250","author":"CY Perng","year":"2003","unstructured":"Perng CY, Kearney AS, Palepu NR, Smith BR, Azzarano LM. Assessment of oral bioavailability enhancing approaches for SB-247083 using flow-through cell dissolution testing as one of the screens. Int J Pharm. 2003;250(1):147\u201356.","journal-title":"Int J Pharm"},{"issue":"2","key":"1685_CR21","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/S0378-5173(00)00415-4","volume":"201","author":"SR Cammarn","year":"2000","unstructured":"Cammarn SR, Sakr A. Predicting dissolution via hydrodynamics: salicylic acid tablets in flow through cell dissolution. Int J Pharm. 2000;201(2):199\u2013209.","journal-title":"Int J Pharm"},{"key":"1685_CR22","doi-asserted-by":"publisher","unstructured":"Real D, Orzan L, Leonardi D, Salomon CJ. Improving the dissolution of Triclabendazole from stable crystalline solid dispersions formulated for oral delivery. AAPS J. 2019;21. https:\/\/doi.org\/10.1208\/s12249-019-1551-4.","DOI":"10.1208\/s12249-019-1551-4"},{"key":"1685_CR23","unstructured":"Committee of National Pharmacopoeia, Pharmacopoeia of P.R.China IV. 2015; 121\u2013122."},{"key":"1685_CR24","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.ejpb.2018.06.022","volume":"130","author":"S Huang","year":"2018","unstructured":"Huang S, Zhang Q, Li H, Sun YQ, Cheng G, Zou M, et al. Increased bioavailability of Efonidipine hydrochloride nanosuspensions by the wet-milling method. Eur J Pharm Biopharm. 2018;130:108\u201314.","journal-title":"Eur J Pharm Biopharm"},{"issue":"1","key":"1685_CR25","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s40005-017-0361-5","volume":"48","author":"X Liu","year":"2018","unstructured":"Liu X, Feng X, Williams RO, Zhang F. Characterization of amorphous solid dispersions. J Pharmaceut Investig. 2018;48(1):19\u201341.","journal-title":"J Pharmaceut Investig"},{"issue":"2","key":"1685_CR26","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1007\/s11095-009-0010-4","volume":"27","author":"DM D\u2019Arcy","year":"2010","unstructured":"D\u2019Arcy DM, Liu B, Bradley G, Healy AM, Corrigan OI. Hydrodynamic and species transfer simulations in the USP 4 dissolution apparatus: considerations for dissolution in a low velocity pulsing flow. Pharm Res. 2010;27(2):246\u201358.","journal-title":"Pharm Res"},{"issue":"3","key":"1685_CR27","first-page":"241","volume":"21","author":"J Thimmasetty","year":"2008","unstructured":"Thimmasetty J, Pandey GS, Babu PRS. Design and in vivo evaluation of carvedilol buccal mucoadhesive patches. Pak J Pharm Sci. 2008;21(3):241\u20138.","journal-title":"Pak J Pharm Sci"},{"issue":"1\u20132","key":"1685_CR28","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0378-5173(00)00554-8","volume":"209","author":"N Yuksel","year":"2000","unstructured":"Yuksel N, Kanik AE, Baykara T. Comparison of in vitro dissolution profiles by ANOVA-based, model-dependent and -independent methods. Int J Pharm. 2000;209(1\u20132):57\u201367.","journal-title":"Int J Pharm"},{"issue":"3","key":"1685_CR29","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1208\/s12248-010-9185-1","volume":"12","author":"Y Zhang","year":"2010","unstructured":"Zhang Y, Huo M, Zhou J, Zou A, Li W, Yao CL, et al. DDSolver: an add-in program for modeling and comparison of drug dissolution profiles. AAPS J. 2010;12(3):263\u201371.","journal-title":"AAPS J"},{"issue":"5","key":"1685_CR30","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.ejps.2004.01.006","volume":"21","author":"NM Volpato","year":"2004","unstructured":"Volpato NM, Silva RL, Brito APP, Gon\u00e7alves JCS, Vaisman M, No\u00ebl F. Multiple level C in vitro\/in vivo correlation of dissolution profiles of two l-thyroxine tablets with pharmacokinetics data obtained from patients treated for hypothyroidism. Eur J Pharm Sci. 2004;21(5):655\u201360.","journal-title":"Eur J Pharm Sci"},{"key":"1685_CR31","first-page":"269","volume":"423","author":"H Malinowski","year":"1997","unstructured":"Malinowski H, Marroum P, Uppoor VR, Gillespie W, Ahn HY, Lockwood P, et al. Draft guidance for industry extended-release solid oral dosage forms. Development, evaluation and application of in vitro-in vivo correlations. Oxygen Transport Tissue XXXIII. 1997;423:269\u201388.","journal-title":"Oxygen Transport Tissue XXXIII"},{"issue":"6","key":"1685_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1208\/s12248-016-9966-2","volume":"18","author":"S Suarez-Sharp","year":"2016","unstructured":"Suarez-Sharp S, Li M, Duan J, Shah H, Seo P. Regulatory experience with In vivo In vitro correlations (IVIVC) in new drug applications. AAPS J. 2016;18(6):1\u201312.","journal-title":"AAPS J"},{"key":"1685_CR33","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1208\/s12248-019-0378-y","volume":"21","author":"MEF Mohamed","year":"2019","unstructured":"Mohamed MEF, Trueman S, Othman AA, Han JH, Ju TR, Marroum P. Development of in vitro\u2013in vivo correlation for Upadacitinib extended-release tablet formulation. AAPS J. 2019;21:108.","journal-title":"AAPS J"},{"issue":"1\u20132","key":"1685_CR34","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.ijpharm.2016.11.063","volume":"519","author":"B Hens","year":"2017","unstructured":"Hens B, Corsetti M, Spiller RC, Marcianib L, Vanuytselc T, Tack J, et al. Exploring gastrointestinal variables affecting drug and formulation behavior: methodologies, challenges and opportunities. Int J Pharm. 2017;519(1\u20132):79\u201397.","journal-title":"Int J Pharm"},{"issue":"4","key":"1685_CR35","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1081\/PDT-120000291","volume":"6","author":"L Tang","year":"2001","unstructured":"Tang L, Khan SU, Muhammad NA. Evaluation and selection of bio-relevant dissolution media for a poorly water-soluble new chemical entity. Pharm Dev Technol. 2001;6(4):531\u201340.","journal-title":"Pharm Dev Technol"},{"issue":"4","key":"1685_CR36","first-page":"560","volume":"29","author":"Y Sun","year":"2009","unstructured":"Sun Y, Tang SF, Gao LQ. Dissolution testing of enalapril maleate tablets with flowing-through cell method and evaluation of in vivo-in vitro correlation. Chin J Pharmaceut Anal. 2009;29(4):560\u20133.","journal-title":"Chin J Pharmaceut Anal"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-020-01685-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-020-01685-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-020-01685-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,30]],"date-time":"2021-05-30T19:03:25Z","timestamp":1622401405000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-020-01685-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,31]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["1685"],"URL":"https:\/\/doi.org\/10.1208\/s12249-020-01685-1","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,31]]},"assertion":[{"value":"2 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"160"}}